NT-0796 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-08-21 in 2mo
ESTIMATED |
READOUT
Study to Explore the Safety and Efficacy of NT-0796 as an Adjunct to Semaglutide
Phase 2 · Obesity |
NodThera Limited | NT-0796 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|